APA (7th ed.) Citation

Healer, J., Thompson, J. K., Mackwell, K. L., Browne, C. D., Seager, B. A., Ngo, A., . . . Cowman, A. F. (2022). RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting. Frontiers in cellular and infection microbiology, 12, 1049065. https://doi.org/10.3389/fcimb.2022.1049065

Chicago Style (17th ed.) Citation

Healer, Julie, et al. "RH5.1-CyRPA-Ripr Antigen Combination Vaccine Shows Little Improvement over RH5.1 in a Preclinical Setting." Frontiers in Cellular and Infection Microbiology 12 (2022): 1049065. https://doi.org/10.3389/fcimb.2022.1049065.

MLA (9th ed.) Citation

Healer, Julie, et al. "RH5.1-CyRPA-Ripr Antigen Combination Vaccine Shows Little Improvement over RH5.1 in a Preclinical Setting." Frontiers in Cellular and Infection Microbiology, vol. 12, 2022, p. 1049065, https://doi.org/10.3389/fcimb.2022.1049065.